Cellero, Visminda P.
HRN: 26-93-56 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFTRIAXONE 1G (VIAL)
04/08/2025
04/14/2025
IV
2g
OD
Non Healing Wound
Waiting Final Action